الصفحة الرئيسية>>Signaling Pathways>> DNA Damage/DNA Repair>> Deubiquitinase>>XL177A

XL177A

رقم الكتالوجGC62517

XL177A هو مثبط USP7 قوي للغاية وانتقائي لا رجعة فيه مع IC50 من 0.34 نانومتريتسبب XL177A في قتل الخلايا السرطانية من خلال آلية تعتمد على p53

Products are for research use only. Not for human use. We do not sell to patients.

XL177A التركيب الكيميائي

Cas No.: 2417089-74-6

الحجم السعر المخزون الكميّة
5 mg
216٫00
متوفر
10 mg
342٫00
متوفر
25 mg
684٫00
متوفر
50 mg
1089٫00
متوفر
100 mg
1800٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

XL177A is a highly potent and selective irreversible USP7 inhibitor with an IC50 of 0.34 nM. XL177A elicits cancer cell killing through a p53-dependent mechanism[1].

XL177A is a potent USP7 inhibitor and p53 stabilizer in cyto. XL177A suppresses cancer cell growth predominantly through a p53-dependent mechanism. XL177A labels the catalytic cysteine, C223, of USP7 with exquisite selectivity for USP7 across the DUBome and human proteome[1]. XL177A (1 μM) induces complete G1 arrest in MCF7 cells after 24 hours[1].Treatment of MCF7 cells, which express WT TP53, with XL177A (0.001- 10 μM) induces rapid degradation of HDM2 within 2 hours, followed by increases in p53 and downstream p21 protein levels[1].

[1]. Nathan J Schauer, et al. Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism. Sci Rep.2020 Mar 24;10(1):5324.

مراجعات

Review for XL177A

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for XL177A

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.